AccessPak for HIV PEP Expanded with Kaletra and Dexrazoxane Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Dextenza Insert
- AccessPak for HIV PEP Expanded with Kaletra-Dextenza intraocular
- AccessPak for HIV PEP Expanded with Kaletra-Dextran 40
- AccessPak for HIV PEP Expanded with Kaletra-Dextran 70 6% in 5% Dextrose high molecular weight
- AccessPak for HIV PEP Expanded with Kaletra-Dextran 75
- AccessPak for HIV PEP Expanded with Kaletra-Dextran high molecular weight
- Dexrazoxane Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Dexrazoxane Intravenous-Accolate
- Dexrazoxane Intravenous-Accretropin
- Dexrazoxane Intravenous-Accucaine
- Dexrazoxane Intravenous-AccuHist Drops
- Dexrazoxane Intravenous-AccuHist PDX Drops